Wardwizard Healthcare Posts Q4 Profit, Reduces Annual Loss; Appoints New CFO

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Wardwizard Healthcare Posts Q4 Profit, Reduces Annual Loss; Appoints New CFO
Overview

Wardwizard Healthcare reported a net profit of ₹0.34 crore in Q4 FY26, a significant improvement from its previous annual loss. However, the company still ended the fiscal year with a net loss of ₹0.32 crore and negative equity. Ms. Harshita Kharva has been appointed as the new CFO.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Wardwizard Healthcare Posts Turnaround in Q4, Year-End Loss Narrows

₹0.34 crore profit in Q4 FY26; ₹0.32 crore net loss for FY26.

Reader Takeaway: Operational recovery evident, but negative net worth and cash flow persist.

What just happened

Wardwizard Healthcare Limited has announced its financial results for the quarter and year ended March 31, 2026. The company reported a net profit of ₹0.3377 crore (approx. ₹34 lakh) for the fourth quarter. For the full fiscal year, the company reduced its net loss to ₹0.3153 crore (approx. ₹32 lakh) from ₹2.7133 crore (approx. ₹2.71 crore) in the previous year. Revenue from operations stood at ₹0.5713 crore for the quarter and ₹0.8441 crore for the year.

The company also announced the appointment of Ms. Harshita Kharva as its new Chief Financial Officer (CFO), effective May 30, 2026. Ms. Kharva is a Chartered Accountant.

Why this matters

The shift to profitability in the fourth quarter and the significant reduction in the annual net loss signal a potential operational turnaround for Wardwizard Healthcare. This improvement could be viewed positively by investors. However, the company continues to face financial challenges, including a negative net worth and negative cash flow from operations.

The backstory

Wardwizard Healthcare has historically struggled with profitability, as evidenced by the larger losses reported in previous years. The company's financial statements often reflect a fragile balance sheet. The appointment of a new CFO is a crucial step in strengthening the financial management and governance structure.

What changes now

With the appointment of Ms. Harshita Kharva, the company gains a new financial steward. Investors will look to her to guide the company towards sustained profitability and improved financial health. The focus will be on her strategy to address the negative net worth and cash flow issues.

Risks to watch

The company's negative net worth of ₹3.3959 crore (approx. ₹3.4 crore) as of March 31, 2026, remains a significant concern. Furthermore, negative net cash from operations of ₹0.1151 crore (approx. ₹12 lakh) for the year indicates that the core business is not generating sufficient cash. These factors highlight the company's financial vulnerability.

Peer comparison

(Information not available in the filing. Grounded search did not yield readily comparable financial data for direct peer comparison on this specific reporting period.)

Context metrics (time-bound)

  • Revenue from Operations: ₹0.5713 crore (Q4 FY26) vs ₹0.8441 crore (FY26)
  • Net Profit/Loss: ₹0.3377 crore (Q4 FY26 Profit) vs ₹-0.3153 crore (FY26 Loss)
  • Total Equity: ₹-3.3959 crore (as of March 31, 2026)
  • Net Cash from Operations: ₹-0.1151 crore (FY26)

What to track next

Investors should monitor Wardwizard Healthcare's ability to sustain quarterly profits and convert the reduced annual loss into an annual profit in the upcoming fiscal year. Key areas to watch include improvements in operating cash flow and strategies to address the negative net worth.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.